Why and how would we implement a lung cancer screening program?

Area of Science:

• Oncology
• Radiology
• Public Health

Background:

• Lung cancer remains a leading cause of cancer incidence and mortality globally.
• Prognosis for lung cancer has seen limited improvement, highlighting the need for early detection strategies.
• Early diagnosis and treatment are crucial for improving lung cancer outcomes.

Purpose of the Study:

• To evaluate the effectiveness of low-dose computed tomography (LDCT) screening for lung cancer.
• To discuss the implications of the National Lung Screening Trial (NLST) findings for clinical practice.
• To address key considerations for implementing lung cancer screening programs.

Main Methods:

• Analysis of the National Lung Screening Trial (NLST), a randomized controlled trial comparing LDCT with chest X-ray.
• Review of ongoing smaller trials investigating LDCT screening.
• Discussion of practical issues related to lung cancer screening implementation.

Main Results:

• Annual LDCT screening reduced lung cancer and overall mortality by 20% and 6.7%, respectively, in high-risk individuals (aged 55-74).
• NLST results are unlikely to be replicated by smaller, underpowered trials.
• Concerns regarding LDCT screening include high false-positive rates, overdiagnosis, and cost.

Conclusions:

• Implementing LDCT lung cancer screening programs for eligible smokers and former smokers is considered reasonable.
• Key factors for successful implementation include defined eligibility criteria, smoking cessation support, primary care physician involvement, and informed decision-making.
• While uncertainties persist, the available evidence supports the judicious use of LDCT screening.